Medison Ventures

What is Medison Ventures?

Medison Ventures is the corporate venture arm of Medison Pharma, a global pharmaceutical company committed to providing access to innovative therapies in international markets.

Focused on fostering cutting-edge innovations across biotech and digital health, they strive to make transformative treatments reachable to patients globally. Beholding transformative healthcare innovation as their north star, Medison Ventures aims to function as a bridge, connecting groundbreaking scientific progress to tangible patient impact.

Harnessing over two decades of Medison Pharma's clinical and commercial acumen, they cultivate proprietary deal-flow generating platforms to identify and orchestrate opportunities that enhance value both for Medison and its partners. Their investment interests range from early to late-stage life sciences and digital health companies, with a specialization in Series A, B, C, and pre-IPO financing. They leverage their network and knowledge to operate essentially as external R&D for Medison's international partners, fueling pipeline advancement that aligns with long-term goals.

Committed to identifying, investing in, and nurturing innovations, their holistic approach encompasses engagement with academic centers, medical institutions, and industry leadership to recognize and foster technologies that are poised to redefine healthcare paradigms. Notable investments include Alpha Tau Medical, Orchard Therapeutics, and Allogene Therapeutics, illustrating their focus on biotechnology and drug discovery. Additionally, their mission encapsulates a dedication to in-license and commercialize highly innovative products within territories supported by Medison, driving strategic growth through a collaborative ecosystem engaging diverse partners.